TrialBioMed research international2015

Potential therapeutic benefit of combining gefitinib and tamoxifen for treating advanced lung adenocarcinoma.

Chien-Ming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.